Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 59, 2024 - Issue 6
Submit an article Journal homepage
685
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials

Anette Mertz NielsenGastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, DenmarkCorrespondence[email protected]
View further author information
,
Klaus TheedeGastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, DenmarkView further author information
,
Lise Lotte GluudGastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, DenmarkView further author information
&
Marianne Kiszka-KanowitzGastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, DenmarkView further author information
Pages 669-673 | Received 30 Nov 2023, Accepted 21 Feb 2024, Published online: 05 Mar 2024

References

  • Stournaras E, Qian W, Pappas A, et al. Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in crohn’s disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease. Gut. 2021;70(4):677–686. doi: 10.1136/gutjnl-2019-320185.
  • Ardabili RA, Jeuring S, Mujagic Z, et al. Classic drugs in the time of new drugs: real-world long-term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2022;56(6):1030–1043. doi: 10.1111/apt.17128.
  • Rispo A, Testa A, De Palma GD, et al. Different profile of efficacy of thiopurines in ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis. 2015;21(11):2570–2575. doi: 10.1097/MIB.0000000000000538.
  • Turbayne AK, Sparrow MJ. Low‑dose azathioprine in combination with allopurinol: the past, present and future of this useful duo. Dig Dis Sci. 2022;67(12):5382–5391. doi: 10.1007/s10620-022-07719-x.
  • Kiszka-Kanowitz M, Theede K, Mertz-Nielsen A. Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease. Scand J Gastroenterol. 2016;51(12):1470–1475. doi: 10.1080/00365521.2016.1216589.
  • Kiszka-Kanowitz M, Theede K, Thomsen SB, et al. Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): an investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial. EClinicalMedicine. 2022;45:101332. doi: 10.1016/j.eclinm.2022.101332.
  • Löwenberg M, Volkers A, van Gennep S, et al. Mercaptopurine for the treatment of ulcerative colitis: a randomized placebo-Controlled trial. J Crohns Colitis. 2023;17(7):1055–1065. doi: 10.1093/ecco-jcc/jjad022.
  • Vasudevan A, Con D, De Cruz P, et al. Clinical trial: combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study). Aliment Pharmacol Ther. 2024;59(4):504–514. doi: 10.1111/apt.17831.
  • van Liere ELSA, Bayoumy AB, Mulder CJJ, et al. Azathioprine with allopurinol is a promising first-line therapy for inflammatory bowel diseases. Dig Dis Sci. 2022;67(8):4008–4019. doi: 10.1007/s10620-021-07273-y.
  • Eriksson C, Rundquist S, Cao Y, et al. Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study. GUT. 2019;68(4):623–632. doi: 10.1136/gutjnl-2017-315521.
  • Casteele NV, Herfarth H, Katz J, et al. American gastroenterological association institute technical review on the role of therapeutic drug monitoring in the management of inflammatory bowel diseases. Gastroenterology. 2017;153(3):835–857.e6. doi: 10.1053/j.gastro.2017.07.031.
  • Duley JA, Florin T. Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides. Ther Drug Monit. 2005;27(5):647–654. doi: 10.1097/01.ftd.0000169061.52715.3e.
  • Dassopoulos T, Dubinsky MC, Bentsen JL, et al. Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn’s disease. Aliment Pharmacol Ther. 2014;39(2):163–175. doi: 10.1111/apt.12555.
  • Hindorf U, Johansson M, Eriksson A, et al. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2009;29(6):654–661. doi: 10.1111/j.1365-2036.2008.03925.x.
  • Maeda T, Sakuraba H, Hiraga H, et al. Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity. Intest Res. 2022;20(1):90–100. doi: 10.5217/ir.2020.00133.
  • Gustavsson A, Halfvarson J, Magnuson A, et al. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era. Am J Gastroenterol. 2007;102(11):2513–2519. doi: 10.1111/j.1572-0241.2007.01435.x.
  • Gisbert JP, Marín AC, Chaparro M. The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2016;111(5):632–647. doi: 10.1038/ajg.2016.54.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.